SNSS - Sunesis under pressure on equity offering July, 29 2020 09:21 AM Viracta Therapeutics Inc Com Sunesis Pharmaceuticals (NASDAQ:SNSS) has priced 52,173,913 common shares at $0.23/share, for gross proceeds of ~$12M.More news on: Sunesis Pharmaceuticals, Inc., Healthcare stocks news, , Stocks on the move, Read more ...